NCT03561259 2023-02-16
OPTIMUM
Jubilant DraxImage Inc.
Phase 2 Unknown
Clinical Trials
5 trialsNCT02943642 2016-10-25
Resimmune®
Angimmune LLC
Phase 2 Unknown
NCT00866762 2011-12-12
A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
Copenhagen University Hospital at Herlev
Phase 2 Unknown
NCT01039363 2009-12-25
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Samsung Medical Center
Phase 2 Unknown
NCT00772798 2008-10-15
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Herlev Hospital
Phase 2 Unknown